Journal article
The "cost" of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice
John Furler, Justin WS Hii, Danny Liew, Irene Blackberry, James Best, Leonie Segal, Doris Young
BMC FAMILY PRACTICE | BMC | Published : 2013
Abstract
BACKGROUND: To describe the current treatment gap in management of cardiovascular risk factors in patients with poorly controlled type 2 diabetes in general practice as well as the associated financial and therapeutic burden of pharmacological treatment. METHODS: Cross-sectional analysis of data from the Patient Engagement and Coaching for Health trial. This totalled 473 patients from 59 general practices with participants eligible if they had HbA1c > 7.5%. Main outcome measures included proportions of patients not within target risk factor levels and weighted average mean annual cost for cardiometabolic medications and factors associated with costs. Medication costs were derived from the Au..
View full abstractRelated Projects (2)
Grants
Awarded by Australian National Health and Medical Research Council (NHMRC)
Funding Acknowledgements
The PEACH study was supported by the Australian National Health and Medical Research Council (NHMRC) (ID 359374 and 566586). We would like to thank the divisions, General Practitioners, Practice Nurses and patients participating in the study.The study is funded by the National Health and Medical Research Council (NHMRC) General Practice Clinical Research Grants program.